Literature DB >> 22712837

XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.

Rensheng Wang1, Xueying Hu, Yang Zhou, Qiming Feng, Li Su, Jianxiong Long, Bo Wei.   

Abstract

The purpose of this study was to evaluate the association between X-ray repair cross-complementing group 1 (XRCC1) gene Arg399Gln and Arg194Trp polymorphisms and childhood acute lymphoblastic leukemia risk (ALL) risk. A systematic search of three databases was conducted. Odds ratios (ORs) with 95% confidence intervals (CIs) for XRCC1 polymorphisms and childhood ALL were calculated with fixed-effects models and random-effects models. This meta-analysis showed that Arg399Gln polymorphism was associated with increased risk of childhood ALL (Gln/Arg vs. Arg/Arg, OR = 1.25, 95% CI = 0.95-1.65, p = 0.032; Gln/Gln vs. Arg/Arg, OR = 1.44, 95% CI = 1.07-1.93, p = 0.448; dominant model, OR = 1.27, 95% CI = 0.98-1.66, p = 0.026; recessive model, OR = 1.16, 95% CI = 0.88-1.53, p = 0.646), while failing to detect links with the Arg194Trp polymorphism studied. In subgroup analyses, the pooled results showed that Arg399Gln polymorphism was associated with an increased risk of childhood ALL in Asians and larger sample size. However, no evidence of a significant association was observed in any subgroup of the Arg194Trp polymorphism. Our results provide evidence that the XRCC1 Arg399Gln polymorphism is associated with an increased risk of childhood ALL in the total population, especially Asians.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22712837     DOI: 10.3109/10428194.2012.704031

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

1.  Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.

Authors:  Jie Li; Zhenzhen Li; Liushun Feng; Wenzhi Guo; Shuijun Zhang
Journal:  Tumour Biol       Date:  2012-10-06

Review 2.  Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia.

Authors:  Kevin Y Urayama; Anand P Chokkalingam; Atsushi Manabe; Shuki Mizutani
Journal:  Int J Hematol       Date:  2012-12-13       Impact factor: 2.490

3.  Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met Polymorphisms in a Turkish Population and Their Association with the Risk of Chronic Lymphocytic Leukemia.

Authors:  Pelin Mutlu; Mualla Pınar Elçi; Murat Yıldırım; Oral Nevruz; Ahmet Türker Çetin; Ferit Avcu
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

4.  No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.

Authors:  Cuiping Li; Xue Xiang; Yang Zhou
Journal:  Mol Biol Rep       Date:  2014-08-03       Impact factor: 2.316

5.  Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia.

Authors:  Claudia Bănescu; Adrian P Trifa; Smaranda Demian; Erzsebeth Benedek Lazar; Delia Dima; Carmen Duicu; Minodora Dobreanu
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

6.  Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.

Authors:  Shahrzad Zehtab; Mahla Sattarzadeh Bardsiri; Roohollah Mirzaee Khalilabadi; Mohsen Ehsan; Ahmad Fatemi
Journal:  BMC Res Notes       Date:  2022-02-14

7.  XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.

Authors:  Yi Bao; Lei Jiang; Jue-Yu Zhou; Jun-Jie Zou; Jiao-Yang Zheng; Xiang-Fang Chen; Zhi-Min Liu; Yong-Quan Shi
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.

Authors:  Lei Jiang; Xiao Fang; Yi Bao; Jue-Yu Zhou; Xiao-Yan Shen; Mao-Hua Ding; Yi Chen; Guo-Han Hu; Yi-Cheng Lu
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.